BIOVENTUS INC. Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2026-03-05: Form 10-K; Exhibit 10.34; Description Form of Letter Agreement Amending Restricted Stock Unit Award Agreements and Grant Notices..
- 2026-03-05: Form 10-K; Exhibit 10.18; Description Form of Bioventus Performance Restricted Stock Unit Award Grant Notice and Agreement (2026)..
- 2025-08-04: Form 8-K; Exhibit 10.1; Description Credit Agreement (the “2025 Credit Agreement”) between Bioventus LLC, Wells Fargo Bank, National Association, as administrative agent, and the lenders and other financial institutions party thereto, dated July 31, 2025..
- 2025-03-11: Form 10-K; Exhibit 10.16; Description Form of Bioventus Performance Restricted Stock Unit Award Grant Notice and Agreement..
| Filed | Form | Exhibit | Description |
|---|---|---|---|
| 2026-03-05 | 10-K | 10.34 | Form of Letter Agreement Amending Restricted Stock Unit Award Agreements and Grant Notices. |
| 2026-03-05 | 10-K | 10.18 | Form of Bioventus Performance Restricted Stock Unit Award Grant Notice and Agreement (2026). |
| 2025-08-04 | 8-K | 10.1 | Credit Agreement (the “2025 Credit Agreement”) between Bioventus LLC, Wells Fargo Bank, National Association, as administrative agent, and the lenders and other financial institutions party thereto, dated July 31, 2025. |
| 2025-03-11 | 10-K | 10.16 | Form of Bioventus Performance Restricted Stock Unit Award Grant Notice and Agreement. |
| 2025-03-11 | 10-K | 10.15 | Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Agreement (2025). |
| 2024-06-21 | 8-K | 10.1 | Amendment No. 1 to the Stockholders Agreement by and among Bioventus Inc., Bioventus LLC and the Principal Stockholders dated as of June 19, 2024. |
| 2024-01-19 | 8-K | 10.1 | Amendment No. 5 to the Credit and Guaranty Agreement by and between Bioventus LLC, Wells Fargo Bank, National Association, as administrative agent and collateral agent, and the lenders and other financial institutions party thereto. |
| 2023-12-21 | 8-K | 10.3 | Form of Bioventus Inc. Inducement Award – Option Agreement. |
| 2023-12-21 | 8-K | 10.2 | Form of Bioventus Inc. Inducement Award – Restricted Stock Unit Agreement. |
| 2023-12-21 | 8-K | 10.1 | Employment Agreement between Robert E. Claypoole and Bioventus Inc., dated as of December 19, 2023. |
| 2023-06-09 | 8-K | 10.2 | Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Agreement. |
| 2023-06-09 | 8-K | 10.1 | Bioventus Inc. 2023 Retention Equity Award Plan. |
| 2023-05-16 | 10-Q | 10.3 | Settlement Agreement by and among CartiHeal (2009) Ltd., Bioventus LLC, Elron Ventures Ltd., and certain other parties detailed therein, dated February 27, 2023 |
| 2023-05-16 | 10-Q | 10.1 | Consulting Agreement between Alessandra Pavesio and Bioventus LLC, dated as of January 1, 2023. |
| 2023-04-11 | 8-K/A | 10.1 | Employment Agreement between Anthony P. Bihl III and Bioventus Inc., dated as of April 5, 2023. |
| 2023-04-05 | 8-K | 10.1 | Separation Agreement and Release between Kenneth Reali and Bioventus Inc., dated April 4, 2023. |
| 2023-03-31 | 10-K | 10.8.D | Amendment No. 4 to Credit and Guaranty Agreement between Bioventus LLC, Guarantor Subsidiaries party thereto, Wells Fargo Bank, National Association, as administrative agent, dated March 31, 2023. |
| 2022-08-12 | 10-Q | 10.3 | Bioventus Inc. 2021 Equity Incentive Plan |
| 2022-07-12 | 8-K | 10.1 | Amendment No. 3 to Credit and Guaranty Agreement between Bioventus LLC, Wells Fargo Bank, National Association, as administrative agent and collateral agent, and the lenders and other financial institutions party thereto, dated July 11, 2022. |
| 2022-06-22 | 8-K | 10.1 | Amendment No. 1 to Option and Equity Purchase Agreement, between the Company, CartiHeal (2009) Ltd. (“CartiHeal”), Elron Ventures Ltd. and ESOP Management and Trust Services Ltd., dated June 17, 2022 |
| 2022-02-28 | 8-K | 10.1 | Employment Agreement, dated February 14, 2022, between the Company and Mark Singleton. |
| 2021-11-22 | 8-K | 10.1 | Lease Agreement, dated November 17, 2021, between Bioventus LLC and 7101 Goodlett Farms Parkway, LLC. |
| 2021-11-10 | 10-Q | 10.1 | Amendment No. 1 to Credit and Guaranty Agreement, dated as of August 29, 2021, by and among Bioventus LLC, certain Guarantor Subsidiaries party thereto, Wells Fargo Bank, National Association, as administrative agent and the lenders and other financial institutions party thereto. |
| 2021-10-29 | 8-K | 10.1 | Amendment No. 2 to Credit and Guaranty Agreement, dated as of October 29, 2021, by and among Bioventus LLC, Oyster Merger Sub I, Inc., Oyster Merger Sub II, LLC, Misonix, Inc., certain Guarantor Subsidiaries party thereto, Wells Fargo Bank, National Association, as administrative agent, and the lenders and other financial institutions party thereto.* |
| 2021-03-31 | 8-K | 10.1 | Agreement and plan of merger, dated as of March 30, 2021, by and among Bioventus LLC, Bioness Inc., Perseus Intermediate, Inc., Perseus Merger Sub, Inc., Alfred E. Mann Living Trust and Mann Group, LLC. |
| 2021-03-26 | 10-K | 10.49 | Settlement Agreement, dated as of February 22, 2021, by and between the United States of America, acting through the United States Attorney’s Office for the Middle District of North Carolina and on behalf of the Office of Inspector General of the Department of Health and Human Services, and Bioventus LLC, through their authorized representatives |
| 2021-02-17 | 8-K | 10.4 | Stockholders Agreement, dated February 16, 2021, by and among Bioventus Inc., Bioventus LLC and the Principal Stockholders |
| 2021-02-17 | 8-K | 10.3 | Registration Rights Agreement, dated February 16, 2021, by and among Bioventus Inc. and the Original LLC Owners |
| 2021-02-17 | 8-K | 10.2 | Tax Receivable Agreement, dated as of February 16, 2021, by and among Bioventus Inc., Bioventus LLC and its Members |
| 2021-02-17 | 8-K | 10.1 | Second Amended and Restated Limited Liability Company Agreement of Bioventus LLC, dated as of February 16, 2021 |